文献速递肝胆胰外科围术期管理与 ERAS

腹腔镜全胰切除联合自体胰岛移植治疗慢性胰腺炎

Laparoscopic Total Pancreatectomy With Islet Autotransplantation and Intraoperative Islet Separation as a Treatment for Patients With Chronic Pancreatitis.
PubMed 文献 · JAMA Surg · 2017-01-01

本研究纳入32例慢性胰腺炎患者,其中20例成功完成腹腔镜全胰切除联合自体胰岛移植(L-TPIAT),2例中转开腹。术后90%患者疼痛减轻或完全缓解,60%停用阿片类药物,25%实现胰岛素独立,表明L-TPIAT安全可行。

要点

  • L-TPIAT在慢性胰腺炎中安全可行,20例成功完成。
  • 术后90%患者疼痛改善,60%停用阿片类药物。
  • 25%患者胰岛素独立,平均HbA1c为7.4%。

核心结论

  • L-TPIAT是首组病例系列,显示其安全可行,可缩短手术时间并带来腹腔镜优势。

研究设计与样本

  • 回顾性病例系列,2013年1月1日至2015年12月31日 tertiary hospital 的32例慢性胰腺炎拟行TPIAT患者,其中20例完成L-TPIAT。

主要发现

  • 平均手术时间493分钟,胰岛分离时间185分钟,热缺血时间51分钟,平均IE计数1325 IE/kg。
  • 平均住院日11天,30天全因再入院率35%(7/20),无手术部位感染、疝、小肠梗阻或死亡。
  • 中位随访6个月,18例(90%)疼痛减轻或完全缓解,12例(60%)停用阿片类药物。
  • 中位随访10.4个月,19例(95%)随机胰岛素C肽可检测到;中位随访12.5个月,5例(25%)胰岛素独立,9例(45%)需1-10 U/d,5例(25%)需11-20 U/d,1例(5%)需>20 U/d基础胰岛素。
  • 平均HbA1c为7.4%(0.5%)。

临床怎么用

  • L-TPIAT可作为慢性胰腺炎患者的一种可行术式,可能缩短住院并加快停用阿片类药物。

局限性

  • 样本量小(20例),单中心,随访时间较短,需更长期验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Pain management of patients with chronic pancreatitis (CP) can be challenging. Laparoscopy has been associated with markedly reduced postoperative pain but has not been widely applied to total pancreatectomy with islet autotransplantation (TPIAT). OBJECTIVE: To examine the feasibility of using laparoscopic TPIAT (L-TPIAT) in the treatment of CP. DESIGN, SETTING, AND PARTICIPANTS: Thirty-two patients with CP presented for TPIAT at a tertiary hospital from January 1, 2013, through December 31, 2015. Of the 22 patients who underwent L-TPIAT, 2 patients converted to an open procedure because of difficult anatomy and prior surgery. Pain and glycemic outcomes were recorded at follow-up visits every 3 to 6 months postoperatively. MAIN OUTCOMES AND MEASURES: Operative outcomes included operative time, islet isolation time, warm ischemia time, islet equivalent (IE) counts, estimated blood loss, fluid resuscitation, and blood transfusions. Postoperative outcomes included length of stay, all-cause 30-day readmission rate, postoperative complications, mortality rate, subjective pain measurements, opioid use, random C-peptide levels, insulin requirements, and glycated hemoglobin level. RESULTS: Of the 32 patients who presented for TPIAT, 20 underwent L-TPIAT (8 men and 12 women; mean [SD] age, 39 [13] years; age range, 21-58 years). Indication for surgery was CP attributable to genetic mutation (n = 9), idiopathic pancreatitis (n = 6), idiopathic pancreatitis with pancreas divisum (n = 3), and alcohol abuse (n = 2). Mean (SD) operative time was 493 (78) minutes, islet isolation time was 185 (37) minutes, and warm ischemia time was 51 (62) minutes. The mean (SD) IE count was 1325 (1093) IE/kg. The mean (SD) length of stay was 11 (5) days, and the all-cause 30-day readmission rate was 35% (7 of 20 patients). None of the patients experienced postoperative surgical site infection, hernia, or small-bowel obstruction, and none died. Eighteen patients (90%) had a decrease or complete resolution of pain, and 12 patients (60%) no longer required opioid therapy at a median follow-up period of 6 months. Postoperative random insulin C-peptide levels were detectable in 19 patients (95%) at a median follow-up of 10.4 months. At a median follow-up of 12.5 months, 5 patients (25%) were insulin independent, whereas 9 patients (45%) required 1 to 10 U/d, 5 patients (25%) required 11 to 20 U/d, and 1 patient (5%) required greater than 20 U/d of basal insulin. The mean (SD) glycated hemoglobin level was 7.4% (0.5%). CONCLUSIONS AND RELEVANCE: This study represents the first series of L-TPIAT, demonstrating its safety and feasibility. Our approach enables patients to experience shorter operative times and the benefits of laparoscopy, including reduced length of stay and quicker opioid independence.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Fan CJ, Hirose K, Walsh CM, et al. Laparoscopic Total Pancreatectomy With Islet Autotransplantation and Intraoperative Islet Separation as a Treatment for Patients With Chronic Pancreatitis. JAMA Surg. 2017. PMID: 28241234. doi:10.1001/jamasurg.2016.5707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。